Fda class ii tuna warning

On 18 September 2026, the U.S. Food and Drug Administration (FDA) officially classified a widespread recall of canned tuna products as a Class II event. This classification indicates that the consumption of the affected products may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. The recall was initiated following reports of potential seal integrity issues in specific production batches, which could lead to spoilage or the growth of harmful pathogens if the cans were compromised during the manufacturing process. The FDA is advising consumers to check their pantries for specific lot codes associated with the affected brands, which were distributed across major retail chains nationwide. While no confirmed illnesses have been linked to the products as of 23 September 2026, the agency is working closely with the manufacturer to ensure all remaining inventory is removed from store shelves. Consumers are urged not to consume any tuna matching the recalled batch numbers and to return the items to the point of purchase for a full refund.